KUKA Aktiengesellschaft

  • WKN: 620440
  • ISIN: DE0006204407
  • Land: Deutschland

Nachricht vom 10.01.2019 | 21:30

KUKA Aktiengesellschaft: Adjustment of Guidance for Fiscal Year 2018

KUKA Aktiengesellschaft / Key word(s): Forecast
KUKA Aktiengesellschaft: Adjustment of Guidance for Fiscal Year 2018

10-Jan-2019 / 21:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

KUKA Aktiengesellschaft
Zugspitzstrasse 140, 86165 Augsburg

- ISIN DE0006204407-
Listed on the following German stock exchanges:
Frankfurt am Main and Munich

Market segment: Prime Standard
Disclosure of Inside Information in accordance with Article 17 MAR
Adjustment of Guidance for Fiscal Year 2018
On January 10, 2019, the Executive Board decided in the context of the preparation of the financial statements 2018 to re-adjust the Guidance communicated in October 2018 for Fiscal Year 2018 (sales revenues of approximately EUR 3.3 billion and EBIT-margin of approximately 4.5% before purchase price allocation, growth investments and reorganization costs). The reasons are primarily that the company is being affected by a stronger slowdown in the automotive and electronic industry in the fourth quarter 2018, ongoing uncertainties in the Chinese automation market and negative impacts from the project business.
According to current estimates, KUKA lowers its guidance for the sales revenues 2018 to approximately EUR 3.2 billion and the EBIT-margin 2018 to approximately 3.0% before purchase price allocation, growth investments and reorganization costs.
Augsburg, January 10, 2019
KUKA Aktiengesellschaft
The Executive Board

Kerstin Heinrich
phone: +49 821 7975-481
fax: +49 821 7975-213
e-mail: kerstin.heinrich@kuka.com

10-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this


Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG beauftragt unabhängige Prüfung

21. Oktober 2019, 07:40

Aktuelle Research-Studie

ad pepper media International N.V.

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Hinzufügen

18. Oktober 2019